Etzkorn, Lacey H. http://orcid.org/0000-0001-7107-2763
Heravi, Amir S.
Knuth, Nicolas D.
Wu, Katherine C.
Post, Wendy S.
Urbanek, Jacek K.
Crainiceanu, Ciprian M.
Funding for this research was provided by:
National Institute on Aging (5T32AG000247)
National Heart, Lung, and Blood Institute (5R01HL125053)
National Institute of Neurological Disorders and Stroke (5R01NS060910)
Article History
Received: 12 May 2022
Revised: 11 May 2023
Accepted: 30 May 2023
First Online: 28 June 2023
Declarations
:
: The results of the study are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation. Drs. Etzkorn, Heravi, Knuth, Wu, and Post report no conflicts of interest with the present work. Dr. Ciprian Crainiceanu is consulting for Bayer, Johnson and Johnson, and Cytel on methods development for wearable and implantable technologies. The details of these contracts are disclosed through the Johns Hopkins University eDisclose system. The research presented here began before this consulting work and is not related to and was supported by this consulting work. Dr. Jacek K. Urbanek contributed to this article as an employee of Johns Hopkins University and the views expressed do not necessarily represent the views of Regeneron Pharmaceuticals Inc.
: All participants in the Towson Accelerometer Study signed informed consent. The Towson Accelerometer Study was approved by the IRB at Towson University (No. 15-A034). All participants of the Multicenter AIDS Cohort study signed consent forms. The collection of data in the MACS was approved by multiple Institutional Review Boards: The Johns Hopkins Bloomberg School of Public Health IRB (No. 84-03-02-01), Advarra IRB (No. 84-03-02-01), University of Pittsburgh IRB (No. STUDY19030406), The Ohio State University Biomedical Sciences IRB (No. 2010H0336), Cook County Health Office of Research & Regulatory Affairs IRB (No. 09-044), Northwestern University IRB (No. STU00022906-CR0004), University of California Los Angeles Office of the Human Research Protection Program (No. 10-001677-AM-00053), and Los Angeles Biomedical Research Institute At Harbor-UCLA Medical Center (No. 10336-14).